Project1061 project protocol

Nicotine withdrawal deficits in BXD strains   (2021)

Gould TJ, Goldberg L




Project protocol - Contents

Procedures

Procedure 1: osmotic minipump treatment

Reagents and solutions

  • saline
  • nicotine hydrogen tartrate salt, Mice received 0.9% sterile saline (SAL) or nicotine hydrogen tartrate salt (NIC, 6.3 mg/kg/day, free base weight-Fisher Scientific, Waltham, MA) dissolved in 0.9% sterile saline, delivered subcutaneously via osmotic mini-pumps (Alzet, Model 1004, Durect, Cupertino, CA) for 12 days. (Fisher Scientific)

Procedure 2: contextual fear conditioning

Equipment, software, and supplies

  • Mouse fear conditioning chamber, Briefly, mice were trained and tested in noise-attenuating chambers (18.8 × 20 × 18.3 cm3, 65 dB background noise; MED Associates, St. Albans, VT). Mice were fear conditioned with two conditioned stimulus (CS, 30 s, 85 dB white noise)–unconditioned stimulus (US, 2 s, 0.57 mA foot shocks) pairings separated by 120 s. Twenty-four hours after training, mice were returned to the training context for 5 min to assess contextual freezing. After contextual testing, mice were placed in distinct chambers (Med Associates)

References

Primary References

Goldberg LR, Kutlu MG, Zeid D, Seemiller LR, Gould TJ. Systems genetic analysis of nicotine withdrawal deficits in hippocampus-dependent learning. Genes Brain Behav. doi: 10.1111/gbb.12734.   PubMed 33797169